ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Japanese Encephalitis Vaccines Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-34A9291
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Japanese Encephalitis Vaccines Market Insights and Forecast to 2028
BUY CHAPTERS

Global Japanese Encephalitis Vaccines Market Research Report 2025

Code: QYRE-Auto-34A9291
Report
September 2025
Pages:67
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi Pasteur
GlaxoSmithKline PLC
Bharat Biotech
China National Biotec Group
Valneva Products

Japanese Encephalitis Vaccines Market Size

The global market for Japanese Encephalitis Vaccines was valued at US$ 231 million in the year 2024 and is projected to reach a revised size of US$ 329 million by 2031, growing at a CAGR of 5.3% during the forecast period.

Japanese Encephalitis Vaccines Market

Japanese Encephalitis Vaccines Market

Epidemic encephalitis (JE) is a disease spreads through mosquito bites. Symptoms usually take 5-15 days to develop and include fever, headache, vomiting, confusion, and difficulty moving. The major form of the disease is encephalitis, and less severe forms such as aseptic meningitis or simple fever syndrome with headache are also frequent. The mortality rate of Japanese encephalitis is high, and sequelae are very common, especially among children (up to 50%). Prevention is possible through the use of inactivated vaccines.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Japanese Encephalitis Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Japanese Encephalitis Vaccines.
The Japanese Encephalitis Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Japanese Encephalitis Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Japanese Encephalitis Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Japanese Encephalitis Vaccines Market Report

Report Metric Details
Report Name Japanese Encephalitis Vaccines Market
Accounted market size in year US$ 231 million
Forecasted market size in 2031 US$ 329 million
CAGR 5.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Attenuated Vaccines
  • Inactivated Vaccines
Segment by Application
  • Adults
  • Children
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi Pasteur, GlaxoSmithKline, Bharat Biotech, China National Biotec Group, Valneva Products
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Japanese Encephalitis Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Japanese Encephalitis Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Japanese Encephalitis Vaccines Market growing?

Ans: The Japanese Encephalitis Vaccines Market witnessing a CAGR of 5.3% during the forecast period 2025-2031.

What is the Japanese Encephalitis Vaccines Market size in 2031?

Ans: The Japanese Encephalitis Vaccines Market size in 2031 will be US$ 329 million.

What is the Japanese Encephalitis Vaccines Market share by application?

Ans: The mortality rate of Japanese encephalitis is high, and sequelae are very common, especially among children (up to 50%).

Who are the main players in the Japanese Encephalitis Vaccines Market report?

Ans: The main players in the Japanese Encephalitis Vaccines Market are Sanofi Pasteur, GlaxoSmithKline, Bharat Biotech, China National Biotec Group, Valneva Products

What are the Application segmentation covered in the Japanese Encephalitis Vaccines Market report?

Ans: The Applications covered in the Japanese Encephalitis Vaccines Market report are Adults, Children

What are the Type segmentation covered in the Japanese Encephalitis Vaccines Market report?

Ans: The Types covered in the Japanese Encephalitis Vaccines Market report are Attenuated Vaccines, Inactivated Vaccines

1 Japanese Encephalitis Vaccines Market Overview
1.1 Product Definition
1.2 Japanese Encephalitis Vaccines by Type
1.2.1 Global Japanese Encephalitis Vaccines Market Value Comparison by Type (2024 VS 2031)
1.2.2 Attenuated Vaccines
1.2.3 Inactivated Vaccines
1.3 Japanese Encephalitis Vaccines by Application
1.3.1 Global Japanese Encephalitis Vaccines Market Value by Application (2024 VS 2031)
1.3.2 Adults
1.3.3 Children
1.4 Global Japanese Encephalitis Vaccines Market Size Estimates and Forecasts
1.4.1 Global Japanese Encephalitis Vaccines Revenue 2020-2031
1.4.2 Global Japanese Encephalitis Vaccines Sales 2020-2031
1.4.3 Global Japanese Encephalitis Vaccines Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Japanese Encephalitis Vaccines Market Competition by Manufacturers
2.1 Global Japanese Encephalitis Vaccines Sales Market Share by Manufacturers (2020-2025)
2.2 Global Japanese Encephalitis Vaccines Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Japanese Encephalitis Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Japanese Encephalitis Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Japanese Encephalitis Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Japanese Encephalitis Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Japanese Encephalitis Vaccines, Date of Enter into This Industry
2.8 Global Japanese Encephalitis Vaccines Market Competitive Situation and Trends
2.8.1 Global Japanese Encephalitis Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Japanese Encephalitis Vaccines Players Market Share by Revenue
2.8.3 Global Japanese Encephalitis Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Japanese Encephalitis Vaccines Market Scenario by Region
3.1 Global Japanese Encephalitis Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Japanese Encephalitis Vaccines Sales by Region: 2020-2031
3.2.1 Global Japanese Encephalitis Vaccines Sales by Region: 2020-2025
3.2.2 Global Japanese Encephalitis Vaccines Sales by Region: 2026-2031
3.3 Global Japanese Encephalitis Vaccines Revenue by Region: 2020-2031
3.3.1 Global Japanese Encephalitis Vaccines Revenue by Region: 2020-2025
3.3.2 Global Japanese Encephalitis Vaccines Revenue by Region: 2026-2031
3.4 North America Japanese Encephalitis Vaccines Market Facts & Figures by Country
3.4.1 North America Japanese Encephalitis Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Japanese Encephalitis Vaccines Sales by Country (2020-2031)
3.4.3 North America Japanese Encephalitis Vaccines Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Japanese Encephalitis Vaccines Market Facts & Figures by Country
3.5.1 Europe Japanese Encephalitis Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Japanese Encephalitis Vaccines Sales by Country (2020-2031)
3.5.3 Europe Japanese Encephalitis Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Japanese Encephalitis Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Japanese Encephalitis Vaccines Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Japanese Encephalitis Vaccines Sales by Region (2020-2031)
3.6.3 Asia Pacific Japanese Encephalitis Vaccines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Japanese Encephalitis Vaccines Market Facts & Figures by Country
3.7.1 Latin America Japanese Encephalitis Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Japanese Encephalitis Vaccines Sales by Country (2020-2031)
3.7.3 Latin America Japanese Encephalitis Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Japanese Encephalitis Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Japanese Encephalitis Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Japanese Encephalitis Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa Japanese Encephalitis Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Japanese Encephalitis Vaccines Sales by Type (2020-2031)
4.1.1 Global Japanese Encephalitis Vaccines Sales by Type (2020-2025)
4.1.2 Global Japanese Encephalitis Vaccines Sales by Type (2026-2031)
4.1.3 Global Japanese Encephalitis Vaccines Sales Market Share by Type (2020-2031)
4.2 Global Japanese Encephalitis Vaccines Revenue by Type (2020-2031)
4.2.1 Global Japanese Encephalitis Vaccines Revenue by Type (2020-2025)
4.2.2 Global Japanese Encephalitis Vaccines Revenue by Type (2026-2031)
4.2.3 Global Japanese Encephalitis Vaccines Revenue Market Share by Type (2020-2031)
4.3 Global Japanese Encephalitis Vaccines Price by Type (2020-2031)
5 Segment by Application
5.1 Global Japanese Encephalitis Vaccines Sales by Application (2020-2031)
5.1.1 Global Japanese Encephalitis Vaccines Sales by Application (2020-2025)
5.1.2 Global Japanese Encephalitis Vaccines Sales by Application (2026-2031)
5.1.3 Global Japanese Encephalitis Vaccines Sales Market Share by Application (2020-2031)
5.2 Global Japanese Encephalitis Vaccines Revenue by Application (2020-2031)
5.2.1 Global Japanese Encephalitis Vaccines Revenue by Application (2020-2025)
5.2.2 Global Japanese Encephalitis Vaccines Revenue by Application (2026-2031)
5.2.3 Global Japanese Encephalitis Vaccines Revenue Market Share by Application (2020-2031)
5.3 Global Japanese Encephalitis Vaccines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Company Information
6.1.2 Sanofi Pasteur Description and Business Overview
6.1.3 Sanofi Pasteur Japanese Encephalitis Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Pasteur Japanese Encephalitis Vaccines Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments/Updates
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Company Information
6.2.2 GlaxoSmithKline Description and Business Overview
6.2.3 GlaxoSmithKline Japanese Encephalitis Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GlaxoSmithKline Japanese Encephalitis Vaccines Product Portfolio
6.2.5 GlaxoSmithKline Recent Developments/Updates
6.3 Bharat Biotech
6.3.1 Bharat Biotech Company Information
6.3.2 Bharat Biotech Description and Business Overview
6.3.3 Bharat Biotech Japanese Encephalitis Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bharat Biotech Japanese Encephalitis Vaccines Product Portfolio
6.3.5 Bharat Biotech Recent Developments/Updates
6.4 China National Biotec Group
6.4.1 China National Biotec Group Company Information
6.4.2 China National Biotec Group Description and Business Overview
6.4.3 China National Biotec Group Japanese Encephalitis Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 China National Biotec Group Japanese Encephalitis Vaccines Product Portfolio
6.4.5 China National Biotec Group Recent Developments/Updates
6.5 Valneva Products
6.5.1 Valneva Products Company Information
6.5.2 Valneva Products Description and Business Overview
6.5.3 Valneva Products Japanese Encephalitis Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Valneva Products Japanese Encephalitis Vaccines Product Portfolio
6.5.5 Valneva Products Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Japanese Encephalitis Vaccines Industry Chain Analysis
7.2 Japanese Encephalitis Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Japanese Encephalitis Vaccines Production Mode & Process Analysis
7.4 Japanese Encephalitis Vaccines Sales and Marketing
7.4.1 Japanese Encephalitis Vaccines Sales Channels
7.4.2 Japanese Encephalitis Vaccines Distributors
7.5 Japanese Encephalitis Vaccines Customer Analysis
8 Japanese Encephalitis Vaccines Market Dynamics
8.1 Japanese Encephalitis Vaccines Industry Trends
8.2 Japanese Encephalitis Vaccines Market Drivers
8.3 Japanese Encephalitis Vaccines Market Challenges
8.4 Japanese Encephalitis Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sanofi Pasteur
GlaxoSmithKline PLC
Bharat Biotech
China National Biotec Group
Valneva Products
List of Tables
 Table 1. Global Japanese Encephalitis Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Japanese Encephalitis Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Japanese Encephalitis Vaccines Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Japanese Encephalitis Vaccines Sales (K Doses) of Key Manufacturers (2020-2025)
 Table 5. Global Japanese Encephalitis Vaccines Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Japanese Encephalitis Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Japanese Encephalitis Vaccines Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Japanese Encephalitis Vaccines Average Price (USD/Dose) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Japanese Encephalitis Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Japanese Encephalitis Vaccines, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Japanese Encephalitis Vaccines, Product Type & Application
 Table 12. Global Key Manufacturers of Japanese Encephalitis Vaccines, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Japanese Encephalitis Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Japanese Encephalitis Vaccines as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Japanese Encephalitis Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Japanese Encephalitis Vaccines Sales by Region (2020-2025) & (K Doses)
 Table 18. Global Japanese Encephalitis Vaccines Sales Market Share by Region (2020-2025)
 Table 19. Global Japanese Encephalitis Vaccines Sales by Region (2026-2031) & (K Doses)
 Table 20. Global Japanese Encephalitis Vaccines Sales Market Share by Region (2026-2031)
 Table 21. Global Japanese Encephalitis Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Japanese Encephalitis Vaccines Revenue Market Share by Region (2020-2025)
 Table 23. Global Japanese Encephalitis Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Japanese Encephalitis Vaccines Revenue Market Share by Region (2026-2031)
 Table 25. North America Japanese Encephalitis Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Japanese Encephalitis Vaccines Sales by Country (2020-2025) & (K Doses)
 Table 27. North America Japanese Encephalitis Vaccines Sales by Country (2026-2031) & (K Doses)
 Table 28. North America Japanese Encephalitis Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Japanese Encephalitis Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Japanese Encephalitis Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Japanese Encephalitis Vaccines Sales by Country (2020-2025) & (K Doses)
 Table 32. Europe Japanese Encephalitis Vaccines Sales by Country (2026-2031) & (K Doses)
 Table 33. Europe Japanese Encephalitis Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Japanese Encephalitis Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Japanese Encephalitis Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Japanese Encephalitis Vaccines Sales by Region (2020-2025) & (K Doses)
 Table 37. Asia Pacific Japanese Encephalitis Vaccines Sales by Region (2026-2031) & (K Doses)
 Table 38. Asia Pacific Japanese Encephalitis Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Japanese Encephalitis Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Japanese Encephalitis Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Japanese Encephalitis Vaccines Sales by Country (2020-2025) & (K Doses)
 Table 42. Latin America Japanese Encephalitis Vaccines Sales by Country (2026-2031) & (K Doses)
 Table 43. Latin America Japanese Encephalitis Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Japanese Encephalitis Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Japanese Encephalitis Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Japanese Encephalitis Vaccines Sales by Country (2020-2025) & (K Doses)
 Table 47. Middle East and Africa Japanese Encephalitis Vaccines Sales by Country (2026-2031) & (K Doses)
 Table 48. Middle East and Africa Japanese Encephalitis Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Japanese Encephalitis Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Japanese Encephalitis Vaccines Sales (K Doses) by Type (2020-2025)
 Table 51. Global Japanese Encephalitis Vaccines Sales (K Doses) by Type (2026-2031)
 Table 52. Global Japanese Encephalitis Vaccines Sales Market Share by Type (2020-2025)
 Table 53. Global Japanese Encephalitis Vaccines Sales Market Share by Type (2026-2031)
 Table 54. Global Japanese Encephalitis Vaccines Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Japanese Encephalitis Vaccines Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Japanese Encephalitis Vaccines Revenue Market Share by Type (2020-2025)
 Table 57. Global Japanese Encephalitis Vaccines Revenue Market Share by Type (2026-2031)
 Table 58. Global Japanese Encephalitis Vaccines Price (USD/Dose) by Type (2020-2025)
 Table 59. Global Japanese Encephalitis Vaccines Price (USD/Dose) by Type (2026-2031)
 Table 60. Global Japanese Encephalitis Vaccines Sales (K Doses) by Application (2020-2025)
 Table 61. Global Japanese Encephalitis Vaccines Sales (K Doses) by Application (2026-2031)
 Table 62. Global Japanese Encephalitis Vaccines Sales Market Share by Application (2020-2025)
 Table 63. Global Japanese Encephalitis Vaccines Sales Market Share by Application (2026-2031)
 Table 64. Global Japanese Encephalitis Vaccines Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Japanese Encephalitis Vaccines Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Japanese Encephalitis Vaccines Revenue Market Share by Application (2020-2025)
 Table 67. Global Japanese Encephalitis Vaccines Revenue Market Share by Application (2026-2031)
 Table 68. Global Japanese Encephalitis Vaccines Price (USD/Dose) by Application (2020-2025)
 Table 69. Global Japanese Encephalitis Vaccines Price (USD/Dose) by Application (2026-2031)
 Table 70. Sanofi Pasteur Company Information
 Table 71. Sanofi Pasteur Description and Business Overview
 Table 72. Sanofi Pasteur Japanese Encephalitis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 73. Sanofi Pasteur Japanese Encephalitis Vaccines Product
 Table 74. Sanofi Pasteur Recent Developments/Updates
 Table 75. GlaxoSmithKline Company Information
 Table 76. GlaxoSmithKline Description and Business Overview
 Table 77. GlaxoSmithKline Japanese Encephalitis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 78. GlaxoSmithKline Japanese Encephalitis Vaccines Product
 Table 79. GlaxoSmithKline Recent Developments/Updates
 Table 80. Bharat Biotech Company Information
 Table 81. Bharat Biotech Description and Business Overview
 Table 82. Bharat Biotech Japanese Encephalitis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 83. Bharat Biotech Japanese Encephalitis Vaccines Product
 Table 84. Bharat Biotech Recent Developments/Updates
 Table 85. China National Biotec Group Company Information
 Table 86. China National Biotec Group Description and Business Overview
 Table 87. China National Biotec Group Japanese Encephalitis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 88. China National Biotec Group Japanese Encephalitis Vaccines Product
 Table 89. China National Biotec Group Recent Developments/Updates
 Table 90. Valneva Products Company Information
 Table 91. Valneva Products Description and Business Overview
 Table 92. Valneva Products Japanese Encephalitis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 93. Valneva Products Japanese Encephalitis Vaccines Product
 Table 94. Valneva Products Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Japanese Encephalitis Vaccines Distributors List
 Table 98. Japanese Encephalitis Vaccines Customers List
 Table 99. Japanese Encephalitis Vaccines Market Trends
 Table 100. Japanese Encephalitis Vaccines Market Drivers
 Table 101. Japanese Encephalitis Vaccines Market Challenges
 Table 102. Japanese Encephalitis Vaccines Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Japanese Encephalitis Vaccines
 Figure 2. Global Japanese Encephalitis Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Japanese Encephalitis Vaccines Market Share by Type: 2024 & 2031
 Figure 4. Attenuated Vaccines Product Picture
 Figure 5. Inactivated Vaccines Product Picture
 Figure 6. Global Japanese Encephalitis Vaccines Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Japanese Encephalitis Vaccines Market Share by Application: 2024 & 2031
 Figure 8. Adults
 Figure 9. Children
 Figure 10. Global Japanese Encephalitis Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Japanese Encephalitis Vaccines Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Japanese Encephalitis Vaccines Sales (2020-2031) & (K Doses)
 Figure 13. Global Japanese Encephalitis Vaccines Average Price (USD/Dose) & (2020-2031)
 Figure 14. Japanese Encephalitis Vaccines Report Years Considered
 Figure 15. Japanese Encephalitis Vaccines Sales Share by Manufacturers in 2024
 Figure 16. Global Japanese Encephalitis Vaccines Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Japanese Encephalitis Vaccines Players: Market Share by Revenue in Japanese Encephalitis Vaccines in 2024
 Figure 18. Japanese Encephalitis Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Japanese Encephalitis Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Japanese Encephalitis Vaccines Sales Market Share by Country (2020-2031)
 Figure 21. North America Japanese Encephalitis Vaccines Revenue Market Share by Country (2020-2031)
 Figure 22. U.S. Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Japanese Encephalitis Vaccines Sales Market Share by Country (2020-2031)
 Figure 25. Europe Japanese Encephalitis Vaccines Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Japanese Encephalitis Vaccines Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Japanese Encephalitis Vaccines Revenue Market Share by Region (2020-2031)
 Figure 33. China Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Taiwan Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Philippines Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Japanese Encephalitis Vaccines Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Japanese Encephalitis Vaccines Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Japanese Encephalitis Vaccines Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Japanese Encephalitis Vaccines Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. U.A.E Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Japanese Encephalitis Vaccines by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Japanese Encephalitis Vaccines by Type (2020-2031)
 Figure 55. Global Japanese Encephalitis Vaccines Price (USD/Dose) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Japanese Encephalitis Vaccines by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Japanese Encephalitis Vaccines by Application (2020-2031)
 Figure 58. Global Japanese Encephalitis Vaccines Price (USD/Dose) by Application (2020-2031)
 Figure 59. Japanese Encephalitis Vaccines Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Live Attenuated Japanese Encephalitis Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Encephalitis Vaccination Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Japanese Encephalitis Inactivated Vaccine Market Research Report 2025
Japanese Encephalitis Virus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Swine Epidemic Encephalitis Inactivated Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Meningitis B Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tick borne Encephalitis Inactivated Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chikungunya Rapid Testing Market Research Report 2025
Encephalitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chikungunya Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rabies Diagnostics Market Research Report 2024
JE Inactivated Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tick borne Encephalitis Vaccine Market Research Report 2024
Global Zika Virus Market Insights Forecast to 2030
Chronic Focal Encephalitis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Zika Virus Therapeutic Market Research Report 2025
Global Zika Virus Testing Market Insights Forecast to 2030
Typhus Fever Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Peste Des Petits Ruminants Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Encephalomyelitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions